SE8400971L - Profylaktiskt och lekande medel for arterioskleros - Google Patents

Profylaktiskt och lekande medel for arterioskleros

Info

Publication number
SE8400971L
SE8400971L SE8400971A SE8400971A SE8400971L SE 8400971 L SE8400971 L SE 8400971L SE 8400971 A SE8400971 A SE 8400971A SE 8400971 A SE8400971 A SE 8400971A SE 8400971 L SE8400971 L SE 8400971L
Authority
SE
Sweden
Prior art keywords
arterios
prophylactic
sclerosis
playing
agents
Prior art date
Application number
SE8400971A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Other versions
SE8400971D0 (sv
Inventor
A Okaniwa
H Iwasaki
K Kitamura
T Morita
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of SE8400971D0 publication Critical patent/SE8400971D0/xx
Publication of SE8400971L publication Critical patent/SE8400971L/

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
SE8400971A 1983-02-25 1984-02-22 Profylaktiskt och lekande medel for arterioskleros SE8400971L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58031515A JPS59157021A (ja) 1983-02-25 1983-02-25 動脈硬化症予防治療剤

Publications (2)

Publication Number Publication Date
SE8400971D0 SE8400971D0 (sv) 1984-02-22
SE8400971L true SE8400971L (sv) 1984-08-26

Family

ID=12333337

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8400971A SE8400971L (sv) 1983-02-25 1984-02-22 Profylaktiskt och lekande medel for arterioskleros

Country Status (12)

Country Link
JP (1) JPS59157021A (ko)
BE (1) BE899000A (ko)
CH (1) CH658389A5 (ko)
DE (1) DE3406837A1 (ko)
DK (1) DK163712C (ko)
FR (1) FR2541577B1 (ko)
GB (1) GB2135192B (ko)
HK (1) HK45389A (ko)
IT (1) IT1178863B (ko)
NL (1) NL8400548A (ko)
SE (1) SE8400971L (ko)
SG (1) SG21189G (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4778791A (en) * 1986-05-16 1988-10-18 Tanabe Seiyaku Co., Ltd. Pharmaceutical composition for improving constitution of lipids in blood
JPS63107925A (ja) * 1986-05-23 1988-05-12 Tanabe Seiyaku Co Ltd 動脈硬化症予防・治療剤
JP2658783B2 (ja) * 1992-12-10 1997-09-30 田辺製薬株式会社 抗動脈硬化剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3562257A (en) * 1967-10-28 1971-02-09 Tanabe Seiyaku Co Benzothiazepine derivatives
GB1236467A (en) * 1967-10-28 1971-06-23 Tanabe Seiyaku Co Benzothiazepine derivatives

Also Published As

Publication number Publication date
DK103084A (da) 1984-08-26
JPS59157021A (ja) 1984-09-06
CH658389A5 (de) 1986-11-14
GB2135192B (en) 1986-10-22
IT1178863B (it) 1987-09-16
JPS6358809B2 (ko) 1988-11-17
GB8405060D0 (en) 1984-04-04
DE3406837A1 (de) 1984-08-30
BE899000A (fr) 1984-06-18
IT8467183A1 (it) 1985-08-24
FR2541577A1 (fr) 1984-08-31
GB2135192A (en) 1984-08-30
DK163712B (da) 1992-03-30
SG21189G (en) 1990-01-26
SE8400971D0 (sv) 1984-02-22
DE3406837C2 (ko) 1990-12-20
HK45389A (en) 1989-06-16
IT8467183A0 (it) 1984-02-24
NL8400548A (nl) 1984-09-17
DK103084D0 (da) 1984-02-24
DK163712C (da) 1992-08-31
FR2541577B1 (fr) 1987-05-22

Similar Documents

Publication Publication Date Title
NO864336L (no) Fremgangsmaate for fremstilling av terapeutisk aktive n-substituerte-n-(3-(1,2,4-triazolo(4,3-6)pyridazin-6-yl)fenyl)alkanamider,-karbamater og -urinstoffer.
NO160850C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(bicykliske heterocyklyl)-4-piperidinaminer.
DK261490D0 (da) New pharmaceutical compound
NO883750L (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
NO910874D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
NO158417C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive urinstoffer og tiourinstoffer.
SE8400971D0 (sv) Profylaktiskt och lekande medel for arterioskleros
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
IT1229223B (it) Composizioni veterinarie sinergisticamente attive e procedimento per la loro preparazione.
GB1537047A (en) Eye ointment
DK392288A (da) Human monoklonale antistoffer samt profylaktiske og terapeutiske midler mod infrektioese sygdomme, der indeholder samme som aktiv bestanddel
SE8402199L (sv) Farmaceutiskt preparat innehallande co-dergocrin och en kalciumantagonist
ES2062398T3 (es) Aroil-ureas.
DE69304266D1 (de) Zusammensetzung enthaltend Dibucaine-Hydrochlorid, ein Salicylat, Calciumbromid und ein antiphlogistisches steroid zur Schmerzbekämpfung
FI944907A (fi) Uusi antineoplastinen sytokiini
ATE68474T1 (de) Aktive substanz in der kardiovaskulaeren therapie.
NO153731C (no) Fremgangsmaate for isolering av fysiologisk aktive pterocarpanforbindelser i krystallinsk form.
ZA843615B (en) 2-alkylthio-1-aminoalkyl-2-pyrroline-3-carbonitriles,processes for their preparation,as well as their use in the prophylaxis and therapy of thrombotic states
IT1232796B (it) Composizioni sinergisticamente attive e procedimento per la loro preparazione.
NO890502D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive etanolamin-derivater.
NO891678L (no) Fremgangsmaate for fremstilling av terapeutisk aktive etanolamin-derivater.